
    
      The study will assess if Continuous Glucose Monitoring (CGM) represents a better tool to
      guide healthcare providers in adjusting insulin therapy, by providing a more complete 24-hour
      assessment of glucose values compared to Point of Care (POC) testing, during hospitalization
      and after hospital discharge in general medicine and surgery patients with T2D and T1D.
    
  